Vaxxinity

Vaxxinity is a global biotechnology company headquartered in the United States that has pioneered a new class of drugs to democratize health. Headquartered in Dallas, Texas, with operations across the U.S., Latin America, Europe, and Asia, its proprietary technology platform enables innovation in synthetic peptide vaccines, designed to prevent or treat infectious diseases, including COVID-19, as well as chronic conditions such as Alzheimer's disease, Parkinson's disease, and migraines. Vaxxinity has optimized its pipeline to potentially achieve a historic global impact on human health.